ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,666Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 930

$557K Total Retail Price of All Prescriptions

Rank: 98 out of 930

692 Patients Receiving at Least One Drug in Part D
88% Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Washington
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

11% of this provider’s 692 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 692 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Washington
SIMVASTATIN 601 571 174 1 3
LISINOPRIL 552 518 171 2 1
ATENOLOL 471 421 134 3 15
OMEPRAZOLE 447 396 143 4 4
LOSARTAN POTASSIUM 439 399 114 5 11
LEVOTHYROXINE SODIUM 362 340 91 6 2
AMLODIPINE BESYLATE 325 309 88 7 5
HYDROCODONE-ACETAMINOPHEN 290 222 85 S3 8 7
METFORMIN HCL 272 239 83 9 9
HYDROCHLOROTHIAZIDE 245 234 76 10 10
WARFARIN SODIUM 232 221 64 11 12
K-TAB ER 229 207 66 12 107
METOPROLOL TARTRATE 203 184 60 13 13
PRAVASTATIN SODIUM 189 184* 58 14 20
FUROSEMIDE 187 155 57 15 8
HUMULIN N 175 152 36 16 125
GLIPIZIDE 172 151 51 17 43
GABAPENTIN 171 135 52 18 14
ZOSTAVAX 155 140 155 19 69
TRAZODONE HCL 154 134 50 20 22
MORPHINE SULFATE ER 147 87 18 S2 21 51
PROAIR HFA 145 130 60 22 35
CLOPIDOGREL 139 134* 35 23 28
OXYCODONE HCL 138 101 34 S2 24 27
HUMULIN R 123 94 29 25 202
LORAZEPAM 114 72 35 B 26 32
ATORVASTATIN CALCIUM 110 96 37 27 6
FAMOTIDINE* 110 87 33 27 93
FLUOXETINE HCL 107 85 33 29 40
MIRTAZAPINE 103 98* 27 30 42
FLUTICASONE PROPIONATE 94 89* 44 31 24
TRIAMTERENE-HYDROCHLOROTHIAZID 94 89* 25 31 149
TAMSULOSIN HCL 93 88* 29 33 23
SERTRALINE HCL 91 78 28 34 21
NORTRIPTYLINE HCL 88 83* 33 35 130
OXYCODONE-ACETAMINOPHEN 88 71 21 S2 35 54
ALLOPURINOL 82 77* 23 37 30
INSULIN SYRINGE* 74 59 19 38 178
TIZANIDINE HCL 72 61 40 39 137
ALENDRONATE SODIUM 71 71 20 40 29
INSULIN SYRINGE* 69 64* 25 41 178
DILT-XR 66 66 19 42 284
CITALOPRAM HBR 66 61* 15 42 17
DOXAZOSIN MESYLATE 64 64 19 44 80
TRAMADOL HCL 58 30 18 45 26
DOXYCYCLINE HYCLATE 58 53* 45 45 217
SPIRIVA 55 50* 18 47 48
CLONIDINE HCL 53 48* 15 48 85
IBUPROFEN 51 38 15 49 91
FINASTERIDE 50 50 13 50 74
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 45* 17 50 47
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.